Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease.
GLP-1受體激動劑和其他胰高血糖素激動劑在非酒精性脂肪肝病中的作用機制和可能的肝保護作用。
Lancet Gastroenterol Hepatol 2023-03-02
Animal studies on glucagon-like peptide-1 receptor agonists and related polyagonists in nonalcoholic fatty liver disease.
葡萄糖樣肽-1 受體激動劑及相關多激動劑在非酒精性脂肪肝病的動物研究。
Hormones (Athens) 2024-03-13
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists.
GLP-1 及雙重 GIP/GLP-1 受體激動劑的作用機制與治療應用。
Front Endocrinol (Lausanne) 2024-08-08